Along these lines, T cell responses against the EBV latency I antigen, particularly in healthy virus carriers frequent EBNA1-specific CD4+ T cells (79, 80), seem to be lost prior to EBV-associated lymphoma development in HIV patients (76). The gene discussed is CD4; the disease is lymphoma.